Filtered By:
Cancer: Lung Cancer
This page shows you your search results in order of relevance. This is page number 4.
Order by Relevance | Date
Total 49680 results found since Jan 2013.
A long-term retrospective observational study at a medium-sized medical oncology service in Switzerland: comparison of overall survival with a national cohort and adherence to treatment guidelines
CONCLUSIONS: The statistically comparable local 1- and 5-year overall survival of the analysed malignancies, with adjustment for stage for the 5-year overall survival for breast cancer, is in line with the national benchmark. Adherence to treatment guidelines is high.PMID:37459836 | DOI:10.57187/smw.2023.40091
Source: Swiss Medical Weekly - July 17, 2023 Category: General Medicine Authors: Mirjam Gross-Erne Lukas Zimmerli Stefano Bassetti Qiyu Li Anita Feller Walter Mingrone Source Type: research
Assessment of reproducibility of cancer survival risk predictions across medical centers
Conclusions:
This study illustrates an analytical approach to assessing reproducibility of predictive models and signatures. Based on the analyses of the two cancer datasets, we conclude that the models with clinical variables appear to perform reasonable well with high degree of consistency and transferability. There should have more investigations on the reproducibility of prediction models including gene expression data across studies.
Source: BMC Medical Research Methodology - Latest articles - February 20, 2013 Category: Research Authors: Hung-Chia ChenJames Chen Source Type: research
NH Woman With Late-Stage Cancer To Get Medical Marijuana Card
CONCORD, N.H. (AP) — New Hampshire health officials have approved a lung cancer patient’s application for an identification card that will allow her to buy medical marijuana in Maine.
A spokesman for the Department of Health and Human Services said Linda Horan would be issued a card Wednesday, a day after a court granted her emergency request and ordered the state to review her application. The state had argued that issuing the 64-year-old Alstead woman a card before dispensaries open next year would undermine its need to control marijuana distribution, but Horan, who was diagnosed with late-stage cancer in July, a...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - November 25, 2015 Category: Consumer Health News Authors: deanreddington Tags: Health Local News Linda Horan Medical Marijuana Source Type: news
Creo Medical looks to raise $25m in UK IPO
U.K.-based electrosurgery device developer Creo Medical said today it looks to raise $25.3 million (UK £20 million) in a U.K. initial public offering, expected to take place on December 9.
Creo Medical said it plans to offer shares at approximately 97¢ per share (UK £0.79), while the company has an estimated market capitalization of approximately $77.7 million (UK £61.3 million).
The company is developing minimally invasive surgical devices, initially focused on gastrointestinal surgery and lung cancer, using the company’s Croma system which combines bipolar radiofrequency and microwave energy technology.
Creo M...
Source: Mass Device - December 6, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Initial Public Offering (IPO) Surgical Creo Medical Source Type: news
Creo Medical wins expanded CE mark for Speedboat RS2 electrosurgical device
Creo Medical said today it won expanded CE mark approval for its Speedboat RS2 electrosurgical device, now cleared for the use of microwave energy as well as radiofrequency.
The U.K.-based company said that in a 30-patient clinical study, the Speedboat RS2 successfully demonstrated safety and efficacy in applying microwave energy to coagulate bleeds in the colon. Creo Medical touted the device as the 1st to use microwave energy combined with radiofrequency.
“Our vision is to enable physicians to move the point of treatment from the operating theatre under general anaesthetic to a procedure under sedation in the endo...
Source: Mass Device - March 24, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Regulatory/Compliance Surgical Vascular Creo Medical Source Type: news
Zebra Medical vision looks to offer AI-assisted imaging scans for $1
Israeli machine-learning radiology firm Zebra Medical Vision said today it plans to launch its AI1 automated imaging analytics tools to healthcare providers for approximately $1 per scan.
The company said it has developed a deep learning engine platform that can detect various medical findings from image scans on its own, including the detection of liver, lung, cardiovascular and bone disease.
Zebra Medical Vision said it is also planning to introduce new capabilities that would cover breast cancer, lung cancer, brain trauma, hypertension and other clinical areas.
“With this new model, we hope to facilitate adoption...
Source: Mass Device - October 27, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Imaging Zebra Medical Vision Source Type: news
Effectiveness of medical thoracoscopy and thoracoscopic talc poudrage in patients with exudative pleural effusion.
CONCLUSION: MT is a safe procedure with high diagnostic yields in undiagnosed pleural effusions. TTP is an effective method to stop recurrence of pleural effusions.
PMID: 26034319 [PubMed - in process]
Source: Singapore Medical Journal - May 1, 2015 Category: Journals (General) Authors: Verma A, Taha A, Venkateswaran S, Tee A Tags: Singapore Med J Source Type: research
Veran Medical pulls in $31m for lung nav device
Veran Medical Technologies said today that it raised a $30.6 million funding round, led by Versant Ventures and River Cities Capital Funds, that it plans to use to expand the commercial footprint of its lung navigation platform.
St. Louis-based Veran said prior backers Prolog Ventures, Advantage Capital, Rex Health Ventures, 3G Capital, Dynamic Investments and Vectis also joined the over-subscribed round.
Veran’s Spin and SpinPerc devices, which compete with Medtronic’s SuperDimension product, combine navigational bronchoscopy and percutaneous navigation, according to its website. The Veran technology is de...
Source: Mass Device - September 22, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Funding Roundup Respiratory Pulmonary Veran Medical Technologies Source Type: news
Uptake Medical touts 1st-in-human use of Intervapor lung cancer device
Uptake Medical said it’s InterVapor targeted vapor therapy system has been used in the 1st-ever regional lung cancer tumor ablation procedure.
The InterVapor uses heated water vapor to reduce bronchoscopic lung volume in patients with heterogenous upper lobe emphysema, the company said.
The patient treated with the system was diagnosed with colorectal cancer that metastasized to the lung. The procedure was performed by Dr. Arschang Valipour at Vienna’s Otto-Wagner-Spital Hospital, Tustin, Calif.-based Uptake said.
“InterVapor is the only therapy with the promise of quick, simple, complete bronchoscopic ab...
Source: Mass Device - October 12, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Respiratory Uptake Medical Source Type: news
